Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 100
11
Diseases
57
Unique genes
0.184
Avg. similarity score
Metachromatic leukodystrophy
Most-connected disease (8 links)
Disease
Searched: Alexander disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Alexander disease
Metachromatic leukodystrophy
Combined saposin deficiency
Retinitis pigmentosa-deafness syndrome
Combined psap deficiency
Gaucher disease
Gaucher disease due to saposin C deficiency
Krabbe disease due to saposin A deficiency
Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome
Hereditary parkinson disease
mucopolysaccharidosis type 6
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Metachromatic leukodystrophy | 8 | 8 | 8 |
| Combined saposin deficiency | 6 | 6 | 2 |
| Retinitis pigmentosa-deafness syndrome | 6 | 6 | 11 |
| Combined psap deficiency | 5 | 5 | 1 |
| Gaucher disease | 5 | 5 | 17 |
| Gaucher disease due to saposin C deficiency | 5 | 5 | 1 |
| Krabbe disease due to saposin A deficiency | 5 | 5 | 1 |
| Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome | 2 | 2 | 1 |
| Hereditary parkinson disease | 2 | 2 | 28 |
| Alexander disease | 1 | 1 | 1 |
| mucopolysaccharidosis type 6 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| PSAP | 8 / 11 | Combined psap deficiency, Combined saposin deficiency, Gaucher disease, Gaucher disease due to saposin C deficiency and 4 more |
| CDH23 | 4 / 11 | Combined saposin deficiency, Gaucher disease, Metachromatic leukodystrophy, Retinitis pigmentosa-deafness syndrome |
| GBA1 | 3 / 11 | Gaucher disease, Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome, Hereditary parkinson disease |
| ARSB | 2 / 11 | Metachromatic leukodystrophy, mucopolysaccharidosis type 6 |
| GFAP | 2 / 11 | Alexander disease, Metachromatic leukodystrophy |
| SNCA | 2 / 11 | Gaucher disease, Hereditary parkinson disease |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Pathways of neurodegeneration - multiple diseases | KEGG | 11 / 480 | 4.8× | 1.29e-5 | 4.04e-4 ✓ sig. |
| Parkinson disease | KEGG | 8 / 268 | 6.3× | 3.55e-5 | 9.38e-4 ✓ sig. |
| Glycosphingolipid metabolism | Reactome | 4 / 46 | 18.3× | 6.41e-5 | 1.52e-3 ✓ sig. |
| Lysosome | KEGG | 5 / 133 | 7.9× | 4.08e-4 | 6.73e-3 ✓ sig. |
| Josephin domain DUBs | Reactome | 2 / 12 | 35.1× | 1.42e-3 | 1.76e-2 ✓ sig. |
| The activation of arylsulfatases | Reactome | 2 / 13 | 32.4× | 1.67e-3 | 1.99e-2 ✓ sig. |
| Sphingolipid metabolism | KEGG | 3 / 54 | 11.7× | 2.12e-3 | 2.38e-2 ✓ sig. |
| MPS VI - Maroteaux-Lamy syndrome | Reactome | 1 / 1 | 211× | 4.75e-3 | 4.22e-2 ✓ sig. |
| Pink/Parkin Mediated Mitophagy | Reactome | 2 / 22 | 19.2× | 4.81e-3 | 4.27e-2 ✓ sig. |
| Mismatch repair | KEGG | 2 / 23 | 18.3× | 5.25e-3 | 4.52e-2 ✓ sig. |
| Cytosolic tRNA aminoacylation | Reactome | 2 / 24 | 17.6× | 5.71e-3 | 4.78e-2 ✓ sig. |
| Defective Mismatch Repair Associated With MSH6 | Reactome | 1 / 2 | 105× | 9.47e-3 | 6.69e-2 |
| NTF3 activates NTRK3 signaling | Reactome | 1 / 2 | 105× | 9.47e-3 | 6.69e-2 |
| Asthma | KEGG | 2 / 32 | 13.2× | 1.00e-2 | 6.92e-2 |
| Defective Mismatch Repair Associated With MSH2 | Reactome | 1 / 3 | 70.2× | 1.42e-2 | 8.56e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| sensory perception of light stimulus | GO:0050953 | 7 / 13 | 177× | 2.84e-15 | 2.03e-12 ✓ sig. |
| equilibrioception | GO:0050957 | 5 / 6 | 273× | 1.32e-12 | 5.89e-10 ✓ sig. |
| photoreceptor cell maintenance | GO:0045494 | 7 / 45 | 51.0× | 6.96e-11 | 2.11e-8 ✓ sig. |
| inner ear receptor cell differentiation | GO:0060113 | 4 / 9 | 146× | 9.69e-9 | 1.64e-6 ✓ sig. |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 5 / 27 | 60.7× | 1.69e-8 | 2.68e-6 ✓ sig. |
| adult locomotory behavior | GO:0008344 | 6 / 56 | 35.1× | 1.77e-8 | 2.77e-6 ✓ sig. |
| regulation of synaptic vesicle transport | GO:1902803 | 3 / 3 | 328× | 2.69e-8 | 3.95e-6 ✓ sig. |
| mitochondrion to lysosome vesicle-mediated transport | GO:0099074 | 3 / 3 | 328× | 2.69e-8 | 3.95e-6 ✓ sig. |
| sensory perception of sound | GO:0007605 | 8 / 162 | 16.2× | 3.09e-8 | 4.45e-6 ✓ sig. |
| dopamine metabolic process | GO:0042417 | 4 / 18 | 72.9× | 2.31e-7 | 2.44e-5 ✓ sig. |
| negative regulation of mitochondrial fission | GO:0090258 | 3 / 5 | 197× | 2.68e-7 | 2.76e-5 ✓ sig. |
| positive regulation of protein localization to cell periphery | GO:1904377 | 3 / 5 | 197× | 2.68e-7 | 2.76e-5 ✓ sig. |
| inner ear auditory receptor cell differentiation | GO:0042491 | 4 / 19 | 69.0× | 2.91e-7 | 2.97e-5 ✓ sig. |
| auditory receptor cell stereocilium organization | GO:0060088 | 4 / 19 | 69.0× | 2.91e-7 | 2.97e-5 ✓ sig. |
| dopamine uptake involved in synaptic transmission | GO:0051583 | 3 / 6 | 164× | 5.35e-7 | 4.94e-5 ✓ sig. |